$ABX

Ganovsky Matthew sold $176K of ABX

Ganovsky Matthew sold 22,800 shares of Abacus Global Management, Inc. (ABX) at $7.74 ($0.18M total) on 2026-09-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Ganovsky Matthew
Published Sep 23, 2026, 9:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ABX
Bearish
medium confidence
Mentioned
$ABX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ABXBearishLow
01

Why it matters

While the sale is modest, it provides transparency and may influence short‑term trading.

02

Market read

Primary disclosure of an insider sale; limited trading relevance.

03

What to watch

The 10b5‑1 plan may have been pre‑scheduled, so the sale does not reflect current sentiment.

Relevance 3/10Novelty 4/10Timing: filing date 2026‑09‑23

Background

Form 4 filings disclose insider transactions; a 10b5‑1 plan allows pre‑arranged sales.

Company-level read

Ticker impact

$ABXBearishMedium confidence
Context

Insider Ganovsky Matthew sold 22,800 shares for $176,472 via a 10b5‑1 plan on 2026‑09‑23.

Expected impact

Potential short‑term dip of 0.5‑1% as the market digests the insider sell.

Evidence & confidence

The transaction size is small relative to total shares outstanding and typical for a 10b5‑1 plan, so impact is limited.

Market effects

Minimal; the sale does not signal sector‑wide trends.

None

None

Counterpoint

The insider sale could be interpreted as a lack of confidence, suggesting a short opportunity.

Key entities

  • Abacus Global Management, Inc.

    Issuer of the stock (ticker ABX).

  • Ganovsky Matthew

    10% owner who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ABXMed

Analysts’ Opinions Are Mixed on These Financial Stocks: Zurich Insurance Group (OtherZFSVF), Abacus Global Management (ABX) and Blackstone Group (BX)

Analysts updated ratings on three financial stocks: Zurich Insurance Group (ZFSVF) received a Hold rating with a CHF520 price target, Abacus Global Management (ABX) a Buy with a $13.50 target, and Blackstone Group (BX) a Buy with a $140 target. Consensus ratings and targets vary, with ZFSVF at Moderate Buy ($712.30), ABX at Strong Buy ($14.13), and BX at Moderate Buy ($145.50).

$ABXMed

Learn Why The Bull Case For Barrick Mining Stock Could Change Following $3b Buyback

Barrick Mining (TSX:ABX) announced a $3b share buyback, reflecting its cash generation. The company is expanding into copper with projects like Reko Diq and Lumwana. Analysts forecast revenue of $24.9b and earnings of $7.1b by 2029, with a fair value estimate of CA$65.74, a 7% upside from the current share price of CA$61.56. The buyback and copper focus are key factors for investors.

$SSRMMed

TSX Ekes into Green by Noon

The TSX rose 21.03 points to 36,654.15 by noon, with BRP gaining 5.7% after an upgrade. SSR Mining and Barrick Mining declined. The Canadian dollar dipped to 72.25 cents. U.S. jobs data boosted Fed rate hike bets, impacting global markets.

$ABXMed

Abacus Global Management affirms FY26 EPS guidance above estimates

Abacus Global Management (NYSE: ABX) reaffirmed its FY26 adjusted EPS guidance of $1.00 to $1.05, exceeding the analyst estimate of $0.99. The company will report Q2 2026 results on August 6, 2026, with a conference call scheduled for the same day. Abacus specializes in alternative asset management and data-driven financial solutions.

$ABXHigh

Abacus Q2 Revenue Rises 30%, Adjusted Net Income Beats Guidance – Minichart

Abacus Global Management (NYSE: ABX) reported Q2 2026 revenue of $73.0M, up 30% YoY. Adjusted net income exceeded guidance at $27.1M. Adjusted EBITDA rose 27% to $39.9M, maintaining a 55% margin. The company deployed $200M in capital, up 62% YoY, and raised its quarterly target to $150M-$175M. It also changed its valuation methodology to a market-based approach. Asset management raised over $1B in the last year, with annualized distributions reaching 10%.